Coloplast CEO to invest in emerging markets: "Our business should be three times larger"

Coloplast CEO Kristian Villumsen wants to grow faster, and more in rapidly developing markets like China, India and Russia, although the company is already doing well. The growth is to mitigate the impact of the reimbursement reform in France.

Photo: Mads Nissen/STF/Ritzau Scanpix

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try MedWatch for 14 days.

Get a trial subscription here.

Do you want a trial subscription with multiple users for yourself and your colleagues?

Read more about your options and find the contact information to our sales team here.

Related articles